EGFR and breast carcinoma: Consequently, this facilitates DNA hypermethylation at the promoter region of microRNA-200a (miRNA-200a), stimulating the expression of hepatocyte growth factor (HGF) and epidermal growth factor receptor (EGFR) and promoting breast cancer progression [19].